# COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

> **NCT06880042** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Dr ayesha wahid** · enrollment: 60 (estimated)

## Conditions studied

- Vitiligo - Macular Depigmentation
- Tacrolimus

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Calcipotriol

## Key facts

- **NCT ID:** NCT06880042
- **Lead sponsor:** Dr ayesha wahid
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06880042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06880042, "COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06880042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*